Dr. Bunker brings years of experience in business developmet with pharmaceutical/biotechnology organizations. Prior to joining ACD Dr. Bunker was Dir. of Business Development at Cell Signaling Technology, Inc. and Genome Therapeutics Corp. He recieved a Ph. D. in Biological Chemistry from Harvard University, an M.B.A. from the Executive Program of Boston University and post-doctoral training in cancer molecular biolog at University of California, San Francisco.